IL-12 expressing saRNA intratumoral therapy (VLP platform)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL-12 expressing saRNA intratumoral therapy (VLP platform), covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer [Phase 1]